MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
BioLife Solutions Book Value 2011-2026 | BLFS
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 349 M | 338 M | 364 M | 478 M | 205 M | 43.5 M | 43.1 M | 10.1 M | 3.17 M | 13.9 B | 13.9 M | -13.3 M | -12.5 M | -11.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.9 B | -13.3 M | 1.12 B |
Quarterly Book Value BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 354 M | 347 M | 353 M | 349 M | 325 M | 321 M | 333 M | 338 M | 332 M | 352 M | 358 M | 364 M | 405 M | 410 M | 476 M | 480 M | 489 M | 452 M | 209 M | 205 M | 205 M | 205 M | 205 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 14.6 M | 43.1 M | 43.1 M | 43.1 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 3.17 M | 3.17 M | 3.17 M | 3.17 M | 9.86 M | 9.86 M | 9.86 M | 9.86 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | -13.3 M | -13.3 M | -13.3 M | -13.3 M | -12.5 M | -12.5 M | -12.5 M | -12.5 M | -11.2 M | -11.2 M | -11.2 M | -11.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 489 M | -13.3 M | 139 M |
Book Value of other stocks in the Medical instruments industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
199 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
76.5 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
22 B | $ 75.8 | -0.08 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
9.03 M | $ 10.99 | 1.48 % | $ 26.7 M | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 64.42 | -0.82 % | $ 12.8 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
257 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
411 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
762 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
388 M | - | -0.05 % | $ 10.3 B | USA |
 |
iRhythm Technologies
IRTC
|
153 M | $ 122.35 | 0.73 % | $ 3.92 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
66.7 M | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
17 M | $ 3.96 | -0.75 % | $ 183 M | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 59.93 | 0.52 % | $ 3.02 B | USA |
 |
electroCore
ECOR
|
-1.71 M | $ 6.18 | -0.08 % | $ 52.4 K | USA |
 |
ICU Medical
ICUI
|
4.05 B | $ 124.82 | 0.22 % | $ 3.08 B | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 26.8 | -0.89 % | $ 4.5 B | USA |
 |
Microbot Medical
MBOT
|
77.6 M | $ 2.2 | 0.92 % | $ 101 M |  Israel |
 |
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
17.9 B | $ 482.22 | 0.71 % | $ 172 B | USA |
 |
Glaukos Corporation
GKOS
|
462 M | $ 121.48 | 0.5 % | $ 5.88 B | USA |
 |
Masimo Corporation
MASI
|
1.05 B | $ 178.63 | -0.04 % | $ 9.52 B | USA |
 |
Milestone Scientific
MLSS
|
2.81 M | $ 0.32 | -1.27 % | $ 26.3 M | USA |
 |
InfuSystem Holdings
INFU
|
48 M | $ 10.34 | 0.68 % | $ 214 M | USA |
 |
Merit Medical Systems
MMSI
|
1.58 B | $ 68.58 | -0.04 % | $ 4.06 B | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 23.02 | -5.07 % | $ 1.55 B | USA |
 |
Retractable Technologies
RVP
|
74.4 M | $ 0.65 | 0.2 % | $ 19.5 M | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 52.1 | 2.24 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
394 M | $ 113.45 | 0.49 % | $ 2.57 B | USA |
 |
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
344 M | $ 25.67 | 3.34 % | $ 1.27 B | USA |
 |
STERIS plc
STE
|
6.62 B | $ 221.8 | -0.77 % | $ 21.9 B | USA |
 |
Stereotaxis
STXS
|
18.7 M | $ 1.93 | -1.53 % | $ 176 M | USA |
 |
Baxter International
BAX
|
6.1 B | $ 18.16 | -1.39 % | $ 9.32 B | USA |
 |
ResMed
RMD
|
3.36 B | $ 219.85 | 0.15 % | $ 32.1 B | USA |
 |
Teleflex Incorporated
TFX
|
3.12 B | $ 136.56 | -0.07 % | $ 6.09 B | USA |
 |
AtriCure
ATRC
|
492 M | $ 29.28 | 3.79 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
13.7 M | $ 6.86 | 1.18 % | $ 305 M | USA |
 |
Utah Medical Products
UTMD
|
119 M | $ 67.17 | -1.03 % | $ 218 M | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
3.18 B | $ 306.16 | -1.14 % | $ 22.1 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 11.91 | 0.08 % | $ 2.37 B | USA |
 |
AngioDynamics
ANGO
|
183 M | $ 11.1 | -0.89 % | $ 453 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 152.14 | -1.74 % | $ 43.8 B | USA |
 |
Nephros
NEPH
|
8.36 M | $ 2.87 | 1.06 % | $ 29.8 M | USA |
 |
OraSure Technologies
OSUR
|
341 M | $ 3.0 | -1.64 % | $ 220 M | USA |
 |
Repligen Corporation
RGEN
|
1.96 B | $ 117.6 | 3.1 % | $ 6.55 M | USA |